- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Scientists at the Imperial College London are researching a treatment for motion sickness by targeting brain signals found to speed up a person’s ability to adapt to motions.
Scientists at the Imperial College London are researching a treatment for motion sickness by targeting brain signals found to speed up a person’s ability to adapt to motions.
According to Reuters:
Research from Imperial College London, recently published in the scientific journal Neurology, explained how motion sickness occurs when what the eyes see and what the inner ear senses are confused. Clinical scientist Dr Qadeer Arshad hit upon the idea for treating motion sickness when investigating what can influence a person’s sense of balance.
Most people are prone to a mild queasy feeling at some point, for example on boats or rollercoasters. But around three in ten people suffer from a more severe type of motion sickness, leading to more unpleasant symptoms, such as dizziness, severe nausea and cold sweats.
Click here to read the entire article on Reuters.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.